Sintx Technologies (SINT) Shares Outstanding (2013 - 2026)
Sintx Technologies (SINT) posted Shares Outstanding (Entity) of $4.8 million for Q2 2026, up 17.72% on a QoQ basis from $4.1 million in Q1 2026, and up 95.0% year-over-year from $2.5 million in Q2 2025.
Analysis
Sintx Technologies (SINT) Shares Outstanding (2013 - 2026) Analysis & Trends
Sintx Technologies has reported Shares Outstanding (Entity) for 14 years, with the latest figure at $4.8 million in Q2 2026.
- On a quarterly basis, Shares Outstanding (Entity) rose 95.0% year-over-year to $4.8 million in Q2 2026; TTM through Jun 2026 was $4.8 million, a 95.0% increase from a year earlier, with the FY2025 full-year figure at $2.8 million, up 274.17% from the prior year.
- Shares Outstanding (Entity) was $4.8 million for Q2 2026 at Sintx Technologies, up from $4.1 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $17.3 million in Q1 2024, with the low at $247136.0 in Q1 2022.
- Average Shares Outstanding (Entity) over 5 years is $3.0 million, with a median of $2.4 million recorded in 2023.
- The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Entity) surged 1602.3% in 2023, then slumped 89.73% in 2025.
- Over 5 years, Shares Outstanding (Entity) stood at $301610.0 in 2022, then jumped by 1138.82% to $3.7 million in 2023, then sank by 80.16% to $741250.0 in 2024, then jumped by 274.17% to $2.8 million in 2025, then soared by 74.83% to $4.8 million in 2026.
- The last three Shares Outstanding (Entity) figures came in at $4.8 million (Q2 2026), $4.1 million (Q1 2026), and $2.8 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 354.10 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 1.28 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 383.50 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 1.47 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 576.40 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 493.20 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 382.20 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 97.60 Mn |
| 10 | Sintx Technologies | 8.73 Mn | 8.73 Mn | - | 4.85 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.85 Mn |
| Mar 31, 2026 | 4.01 Mn |
| Dec 31, 2025 | 2.77 Mn |
| Sep 30, 2025 | 2.96 Mn |
| Jun 30, 2025 | 2.54 Mn |
| Mar 31, 2025 | 1.77 Mn |
| Dec 31, 2024 | 741,250.00 |
| Sep 30, 2024 | 896,305.00 |
| Jun 30, 2024 | 631,212.00 |
| Mar 31, 2024 | 17.26 Mn |
| Dec 31, 2023 | 3.74 Mn |
| Sep 30, 2023 | 4.21 Mn |
| Jun 30, 2023 | 4.07 Mn |
| Mar 31, 2023 | 2.27 Mn |
| Dec 31, 2022 | 301,610.00 |
| Sep 30, 2022 | 247,248.00 |
| Jun 30, 2022 | 247,166.00 |
| Mar 31, 2022 | 247,122.00 |
| Dec 31, 2021 | 246,919.00 |
| Sep 30, 2021 | 247,032.00 |